• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.13%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    163.91 Down 0.87(0.53%) 4:00PM EDT
    |After Hours : 164.49 Up 0.58 (0.35%) 5:17PM EDT
    Add to Portfolio
    Prev Close:164.78
    Open:163.58
    Bid:163.81 x 1500
    Ask:163.89 x 1200
    1y Target Est:209.28
    Beta:1.18
    Earnings Date:Jul 22 - Jul 27 (Est.)
    Day's Range:162.50 - 165.00
    52wk Range:150.06 - 203.30
    Volume:1,830,121
    Avg Vol (3m):1,798,540
    Market Cap:32.72B
    P/E (ttm):56.15
    EPS (ttm):2.92
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALXNDown 0.53%32.72B
    AMGNDown 0.38%118.95B
    BAXUp 0.03%36.07B

    Key Statistics

    Forward P/E (1 yr):28.26
    P/S (ttm):14.50
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :4.94
    Quarterly EPS Est (Jun-15) :1.38
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):2.17

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback